# CD160 Expression in Corneal Vessels

> **NCT05009407** · — · COMPLETED · sponsor: **CHU de Reims** · enrollment: 43 (actual)

## Conditions studied

- Corneal Graft Rejection
- CD160
- Angiogenesis
- Lymphangiogenesis

## Interventions

- **BIOLOGICAL:** Immunohistochemistry and clinical analyses on patients and corneas

## Key facts

- **NCT ID:** NCT05009407
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-21
- **Primary completion:** 2025-12-22
- **Final completion:** 2025-12-22
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05009407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05009407, "CD160 Expression in Corneal Vessels". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05009407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*